![Randomized phase
<scp>II</scp>
trial of survivin 2B peptide vaccination for patients with
<scp>HLA</scp>
‐A24‐positive pancreatic adenocarcinoma]()
Randomized phase
<scp>II</scp>
trial of survivin 2B peptide vaccination for patients with
<scp>HLA</scp>
‐A24‐positive pancreatic adenocarcinomaShima, Hiroaki; Tsurita, Giichiro; Wada, Satoshi; Hirohashi, Yoshihiko; Yasui, Hiroshi; Hayashi, Hiroshi; Miyakoshi, Takashi; Watanabe, Kazue; Murai, Aiko; Asanuma, Hiroko; Tokita, Serina; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Nakae, Yutaka; Sugita, Osamu; Ito, Yoichi M.; Ota, Yasunori; Kimura, Yasutoshi; Kutomi, Goro; Hirata, Koichi; Mizuguchi, Toru; Imai, Kohzoh; Takemasa, Ichiro; Sato, Noriyuki; Torigoe, Toshihiko · Cancer Science · 2019